How does CNVI's PS Ratio compare to its peers?

CNVI is good value based on its Price-To-Sales Ratio (9.7x) compared to the peer average (28.7x).

How does CNVI's PS Ratio compare vs other companies in the CA Medical Equipment Industry?

CNVI is expensive based on its Price-To-Sales Ratio (9.7x) compared to the North American Medical Equipment industry average (3.3x).

What is CNVI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate CNVI's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of CNVI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate CNVI's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Conavi Medical (TSXV:CNVI) - Stock Price, News & Analysis

CNVI Stock Overview

Focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. More details

CNVI fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Revenue grew by 48.7% over the past year

Risk Analysis

Shares are highly illiquid

Has less than 1 year of cash runway

Negative shareholders equity

Does not have meaningful revenue (CA$4M)

+ 1 more risk

Conavi Medical Corp. Competitors

Aurora Spine

TSXV:ASG

CA$34.8m

Nanalysis Scientific

TSXV:NSCI

CA$41.8m

Perimeter Medical Imaging AI

TSXV:PINK

CA$57.9m

NuGen Medical Devices

TSXV:NGMD

CA$18.5m

Price History & Performance

Summary of all time highs, changes and price drops for Conavi Medical
Historical stock prices
Current Share Price	CA$0.80
52 Week High	CA$1.52
52 Week Low	CA$0.80
Beta	0
11 Month Change	-28.57%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-28.89%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CNVI	CA Medical Equipment	CA Market
7D	-11.1%	-1.4%	2.1%
1Y	n/a	2.0%	23.4%

Return vs Industry: Insufficient data to determine how CNVI performed against the Canadian Medical Equipment industry.

Return vs Market: Insufficient data to determine how CNVI performed against the Canadian Market.

Price Volatility

Is CNVI's price volatile compared to industry and market?
CNVI volatility
CNVI Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	13.2%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	2.9%

Stable Share Price: CNVI's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine CNVI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Tom Looby	conavi.com

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.

Conavi Medical Corp. Fundamentals Summary

How do Conavi Medical's earnings and revenue compare to its market cap?
CNVI fundamental statistics
Market cap	CA$37.17m
Earnings (TTM)	-CA$34.58m
Revenue (TTM)	CA$3.64m

9.7x

P/S Ratio

-1.0x

P/E Ratio

Is CNVI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CNVI income statement (TTM)
Revenue	CA$3.64m
Cost of Revenue	CA$2.25m
Gross Profit	CA$1.39m
Other Expenses	CA$35.98m
Earnings	-CA$34.58m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.78
Gross Margin	38.28%
Net Profit Margin	-949.62%
Debt/Equity Ratio	-98.2%

How did CNVI perform over the long term?

See historical performance and comparison